Stephanie Judd Irwin, MD | |
915 E 1st St, Duluth, MN 55805-2107 | |
(218) 249-5439 | |
Not Available |
Full Name | Stephanie Judd Irwin |
---|---|
Gender | Female |
Speciality | Gastroenterology |
Experience | 15 Years |
Location | 915 E 1st St, Duluth, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831328707 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 4301094318 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Lukes Hospital | Duluth, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Lukes Hospital Of Duluth | 7113834839 | 352 |
St Lukes Hospital Of Duluth | 7113834839 | 352 |
News Archive
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from Boehringer Ingelheim for achievement of a performance milestone in their 11beta-hydroxysteroid dehydrogenase (HSD)-1 diabetes and metabolic disease strategic alliance.
Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.
For the first time, in 2009, The Leapfrog Group asked hospitals across the country on behalf of Leapfrog's purchaser members to publicly report their rates of one of the most common and deadly forms of hospital-acquired infections: central-line associated blood stream infections, or CLABSIs.
Anthony Zador, Ph.D., Professor of Biology and Program Chair in Neuroscience at Cold Spring Harbor Laboratory (CSHL), has been awarded a $2.17 million, 5-year grant by the National Institutes of Health (NIH)'s Transformative Research Projects Program (T-R01).
› Verified 8 days ago
Entity Name | St Lukes Hospital Of Duluth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902845068 PECOS PAC ID: 7113834839 Enrollment ID: O20031120000212 |
News Archive
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from Boehringer Ingelheim for achievement of a performance milestone in their 11beta-hydroxysteroid dehydrogenase (HSD)-1 diabetes and metabolic disease strategic alliance.
Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.
For the first time, in 2009, The Leapfrog Group asked hospitals across the country on behalf of Leapfrog's purchaser members to publicly report their rates of one of the most common and deadly forms of hospital-acquired infections: central-line associated blood stream infections, or CLABSIs.
Anthony Zador, Ph.D., Professor of Biology and Program Chair in Neuroscience at Cold Spring Harbor Laboratory (CSHL), has been awarded a $2.17 million, 5-year grant by the National Institutes of Health (NIH)'s Transformative Research Projects Program (T-R01).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Stephanie Judd Irwin, MD 915 E 1st St, Duluth, MN 55805-2107 Ph: (218) 249-5439 | Stephanie Judd Irwin, MD 915 E 1st St, Duluth, MN 55805-2107 Ph: (218) 249-5439 |
News Archive
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from Boehringer Ingelheim for achievement of a performance milestone in their 11beta-hydroxysteroid dehydrogenase (HSD)-1 diabetes and metabolic disease strategic alliance.
Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.
For the first time, in 2009, The Leapfrog Group asked hospitals across the country on behalf of Leapfrog's purchaser members to publicly report their rates of one of the most common and deadly forms of hospital-acquired infections: central-line associated blood stream infections, or CLABSIs.
Anthony Zador, Ph.D., Professor of Biology and Program Chair in Neuroscience at Cold Spring Harbor Laboratory (CSHL), has been awarded a $2.17 million, 5-year grant by the National Institutes of Health (NIH)'s Transformative Research Projects Program (T-R01).
› Verified 8 days ago
Nizar Najib Saleh, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Joseph J Martinelli, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Ste P201, Duluth, MN 55805 Phone: 218-249-7970 | |
Gina Marie Slipka-marinos, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Abdurrahman M Hamadah, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St Ste L201, Duluth, MN 55802 Phone: 218-249-5555 | |
Sarah Jane Nelson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Robert Dale Niedringhaus, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Thomas Edward Russ, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |